Dimitri Messeri

417 total citations
9 papers, 267 citations indexed

About

Dimitri Messeri is a scholar working on Electrical and Electronic Engineering, Surgery and Genetics. According to data from OpenAlex, Dimitri Messeri has authored 9 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Electrical and Electronic Engineering, 2 papers in Surgery and 2 papers in Genetics. Recurrent topics in Dimitri Messeri's work include Electrochemical sensors and biosensors (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Breast Cancer Treatment Studies (2 papers). Dimitri Messeri is often cited by papers focused on Electrochemical sensors and biosensors (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Breast Cancer Treatment Studies (2 papers). Dimitri Messeri collaborates with scholars based in Italy, United Kingdom and Finland. Dimitri Messeri's co-authors include Alessandro Poscia, Francesco Ricci, Danila Moscone, David Parker, Mauro Botta, Mark P. Lowe, Giuseppe Palleschi, Aziz Amine, Carol Moreno and Peter Johansson and has published in prestigious journals such as Chemical Communications, Annals of Oncology and Biosensors and Bioelectronics.

In The Last Decade

Dimitri Messeri

9 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimitri Messeri Italy	7	82	58	57	56	54	9	267
Mawei Jiang China	13	37 0.5×	26 0.4×	39 0.7×	37 0.7×	109 2.0×	24	479
Ruichun Li China	10	75 0.9×	29 0.5×	17 0.3×	26 0.5×	16 0.3×	40	308
J. Brundell Sweden	7	99 1.2×	13 0.2×	9 0.2×	9 0.2×	94 1.7×	9	360
Xinhua Tian China	13	45 0.5×	16 0.3×	10 0.2×	91 1.6×	139 2.6×	28	524
Xinyuan Hu China	11	30 0.4×	45 0.8×	28 0.5×	69 1.2×	68 1.3×	36	441
Erica Bertocci Italy	8	97 1.2×	9 0.2×	8 0.1×	32 0.6×	23 0.4×	14	406
Guruguhan Meenakshisundaram United States	8	6 0.1×	32 0.6×	13 0.2×	56 1.0×	34 0.6×	8	412
Shanting Liu China	10	39 0.5×	4 0.1×	8 0.1×	135 2.4×	38 0.7×	33	365
Cejun Yang China	10	10 0.1×	41 0.7×	13 0.2×	49 0.9×	73 1.4×	18	360

Countries citing papers authored by Dimitri Messeri

Since Specialization

Citations

This map shows the geographic impact of Dimitri Messeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Messeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Messeri more than expected).

Fields of papers citing papers by Dimitri Messeri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Messeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Messeri. The network helps show where Dimitri Messeri may publish in the future.

Co-authorship network of co-authors of Dimitri Messeri

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Messeri. A scholar is included among the top collaborators of Dimitri Messeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Messeri. Dimitri Messeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

O’Shaughnessy, Joyce, Juan Jesús Cruz, Lesley Fallowfield, et al.. (2020). 80O Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+ eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study. Annals of Oncology. 31. S42–S42. 3 indexed citations

O’Shaughnessy, Joyce, Susana Sousa, Juan Jesús Cruz, et al.. (2020). 165MO Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study. Annals of Oncology. 31. S306–S307. 6 indexed citations

Michallet, Anne‐Sophie, Melih Aktan, Wolfgang Hiddemann, et al.. (2018). Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study. Haematologica. 103(4). 698–706. 50 indexed citations

Aktan, Meryem, Anna Schuh, Peter Johansson, et al.. (2015). Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study. Leukemia & lymphoma. 56. 149–149. 10 indexed citations

Ricci, Francesco, Alessandro Poscia, Dimitri Messeri, et al.. (2006). Toward continuous glucose monitoring with planar modified biosensors and microdialysis. Biosensors and Bioelectronics. 22(9-10). 2032–2039. 38 indexed citations

Poscia, Alessandro, et al.. (2005). A novel continuous subcutaneous lactate monitoring system. Biosensors and Bioelectronics. 20(11). 2244–2250. 39 indexed citations

Ricci, Francesco, Danila Moscone, Giuseppe Palleschi, et al.. (2005). Novel planar glucose biosensors for continuous monitoring use. Biosensors and Bioelectronics. 20(10). 1993–2000. 59 indexed citations

Vertommen, Jan, Pascale Abrams, Luc Van Gaal, et al.. (2004). Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device. Diabetes/Metabolism Research and Reviews. 20(S2). S24–S31. 12 indexed citations

Messeri, Dimitri, Mark P. Lowe, David Parker, & Mauro Botta. (2001). A stable, high relaxivity, diaqua gadolinium complex that suppresses anion and protein bindingElectronic supplementary information (ESI) available: pH dependence of europium emission spectra, stability screening details and relaxivity/pH plots for selected Gd complexes. See http://www.rsc.org/suppdata/cc/b1/b108294a/. Chemical Communications. 2742–2743. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact